Announced Sat, 23 May · 20:02 IST

The Board approved the appointment of Mr. Vaibhav Odhekar as an Additional Executive Director for 5 years

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+9.1%1-day move
₹113.67
prior close
₹116.99
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-7.9-7.9-7.9-7.9+9.1+14.8+19.5+14.9+12.7+8.2+3.5+15.5-3.4
Up moveDown movePending
AI summary

The Board of Directors of Aspira Pathlab & Diagnostics Ltd approved three key appointments on May 23, 2026. Mr. Vaibhav Odhekar has been appointed as Additional Executive Director for a 5-year term, effective from May 23, 2026, subject to shareholder approval. Mr. Odhekar is an experienced entrepreneur with over 20 years in technology-led platform businesses across Asia, co-founding POKKT (later merged with AnyMind Group, Japan). The board also appointed Mrs. Neetu Maurya as Company Secretary and Compliance Officer from May 24, 2026, and M/s. Vishal J Bhanushali & Associates as Internal Auditor for FY 2026-27. The company has confirmed that Mr. Odhekar is not debarred from holding a director position.

Likely market impact

The appointment of an experienced technology and business executive like Mr. Odhekar could bring strategic value to Aspira's expansion plans. However, since this is an 'Additional' director appointment pending shareholder approval, it is a routine governance matter with limited immediate impact on the stock.